My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 484

    1.

    Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California.

    Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ.

    Ann Intern Med. 2000 Feb 1;132(3):182-90.PMID: 10651598 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization.

    Flannery B, Heffernan RT, Harrison LH, Ray SM, Reingold AL, Hadler J, Schaffner W, Lynfield R, Thomas AR, Li J, Campsmith M, Whitney CG, Schuchat A.

    Ann Intern Med. 2006 Jan 3;144(1):1-9.PMID: 16389249 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000.

    Heffernan RT, Barrett NL, Gallagher KM, Hadler JL, Harrison LH, Reingold AL, Khoshnood K, Holford TR, Schuchat A.

    J Infect Dis. 2005 Jun 15;191(12):2038-45. Epub 2005 May 11.PMID: 15897989 [PubMed - indexed for MEDLINE]Related articles

    4.

    Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study.

    Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM, Vugia DJ, Reingold AL.

    Ann Intern Med. 1998 Nov 1;129(9):698-704.PMID: 9841601 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

    Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

    Clin Infect Dis. 2008 Aug 15;47(4):476-84.PMID: 18627249 [PubMed - indexed for MEDLINE]Related articles

    6.

    The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.

    Jones N, Huebner R, Khoosal M, Crewe-Brown H, Klugman K.

    AIDS. 1998 Nov 12;12(16):2177-84.PMID: 9833859 [PubMed - indexed for MEDLINE]Related articles

    7.

    Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.

    Flannery B, Schrag S, Bennett NM, Lynfield R, Harrison LH, Reingold A, Cieslak PR, Hadler J, Farley MM, Facklam RR, Zell ER, Whitney CG; Active Bacterial Core Surveillance/Emerging Infections Program Network.

    JAMA. 2004 May 12;291(18):2197-203.PMID: 15138241 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy.

    Harrison LH, Dwyer DM, Billmann L, Kolczak MS, Schuchat A.

    Arch Intern Med. 2000 Jan 10;160(1):89-94.PMID: 10632309 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

    Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network.

    JAMA. 2001 Apr 4;285(13):1729-35.PMID: 11277827 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

    Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network.

    N Engl J Med. 2003 May 1;348(18):1737-46.PMID: 12724479 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

    Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.

    Pediatr Infect Dis J. 2007 Sep;26(9):771-7.PMID: 17721369 [PubMed - indexed for MEDLINE]Related articles

    12.

    Herd immunity and pneumococcal conjugate vaccine: a quantitative model.

    Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.

    Vaccine. 2007 Jul 20;25(29):5390-8. Epub 2007 May 22.PMID: 17583392 [PubMed - indexed for MEDLINE]Related articles

    13.

    Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group.

    Plouffe JF, Breiman RF, Facklam RR.

    JAMA. 1996 Jan 17;275(3):194-8.PMID: 8604171 [PubMed - indexed for MEDLINE]Related articles

    14.

    Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

    Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B.

    Pediatr Infect Dis J. 2004 Jun;23(6):485-9.PMID: 15194827 [PubMed - indexed for MEDLINE]Related articles

    15.

    Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.

    Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J; Massachusetts Department of Public Health Epidemiologists.

    Pediatr Infect Dis J. 2005 Jan;24(1):17-23.PMID: 15665705 [PubMed - indexed for MEDLINE]Related articles

    16.

    Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

    Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG; Active Bacterial Core Surveillance Team.

    JAMA. 2005 Oct 26;294(16):2043-51.PMID: 16249418 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Invasive pneumococcal disease in an underimmunized, high HIV prevalence population.

    Tasslimi A, Wenger P, Pentakota SR, Brimacombe M, Burday M, Sinha A.

    J Infect. 2008 Feb;56(2):99-102. Epub 2008 Jan 10.PMID: 18190966 [PubMed - indexed for MEDLINE]Related articles

    18.

    Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients.

    Breiman RF, Keller DW, Phelan MA, Sniadack DH, Stephens DS, Rimland D, Farley MM, Schuchat A, Reingold AL.

    Arch Intern Med. 2000 Sep 25;160(17):2633-8.PMID: 10999977 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough.

    Vergison A, Tuerlinckx D, Verhaegen J, Malfroot A; Belgian Invasive Pneumococcal Disease Study Group.

    Pediatrics. 2006 Sep;118(3):e801-9. Epub 2006 Aug 7.PMID: 16894008 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.

    Watson M, Bayley K, Bell JM, Gilbert GL, Hogg G, Keil AD, Krause V, Murphy D, Roche P, Smith HV, Stewart MG, Stylianopoulos J, Turnidge J.

    Commun Dis Intell. 2003;27(4):478-87.PMID: 15508501 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity